Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hypoxia-Inducible Factor and Its Role in the Management of Anemia in Chronic Kidney Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 2, Pages 389
Publisher
MDPI AG
Online
2018-01-29
DOI
10.3390/ijms19020389
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
- (2017) Kristina Petrulienė et al. Medicina-Lithuania
- Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in hemodialysis patients
- (2017) Kristina Petrulienė et al. Medicina-Lithuania
- A Novel Hypoxia-Inducible Factor−Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial
- (2016) Richard A. Brigandi et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study
- (2016) Robert Provenzano et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Iron therapy in chronic kidney disease: Recent changes, benefits and risks
- (2016) Sandra Ribeiro et al. BLOOD REVIEWS
- Deletion or Inhibition of the Oxygen Sensor PHD1 Protects against Ischemic Stroke via Reprogramming of Neuronal Metabolism
- (2016) Annelies Quaegebeur et al. Cell Metabolism
- Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
- (2016) R. Provenzano et al. Clinical Journal of the American Society of Nephrology
- Conditional Deletion of Prolyl Hydroxylase Domain-Containing Protein 2 (Phd2) Gene Reveals Its Essential Role in Chondrocyte Function and Endochondral Bone Formation
- (2016) Shaohong Cheng et al. ENDOCRINOLOGY
- Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia
- (2016) Elke Marsch et al. EUROPEAN HEART JOURNAL
- Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
- (2016) Mun Chiang Chan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells
- (2016) Martina Rauner et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Association of Increased Serum Ferritin With Impaired Muscle Strength/Quality in Hemodialysis Patients
- (2016) Chie Nakagawa et al. JOURNAL OF RENAL NUTRITION
- Vadadustat, a novel oral HIF stabilizer, provides effective anemia treatment in nondialysis-dependent chronic kidney disease
- (2016) Pablo E. Pergola et al. KIDNEY INTERNATIONAL
- Impact of Oxidative Stress in Premature Aging and Iron Overload in Hemodialysis Patients
- (2016) Blanca Murillo-Ortiz et al. Oxidative Medicine and Cellular Longevity
- Safety Issues in Iron Treatment in CKD
- (2016) Nosratola D. Vaziri SEMINARS IN NEPHROLOGY
- Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice
- (2016) Amandine Thomas et al. Scientific Reports
- Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing
- (2015) A. Karaboyas et al. Clinical Journal of the American Society of Nephrology
- Oral Delivery of Prolyl Hydroxylase Inhibitor
- (2015) Ellen Marks et al. INFLAMMATORY BOWEL DISEASES
- Depletion of PHD3 protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis
- (2015) Liang Xie et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Excess mortality attributable to chronic kidney disease. Results from the PIRP project
- (2015) Dino Gibertoni et al. JOURNAL OF NEPHROLOGY
- Four-Week Studies of Oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
- (2015) L. Holdstock et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Roxadustat (FG-4592): Correction of Anemia in Incident Dialysis Patients
- (2015) A. Besarab et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality
- (2015) George R. Bailie et al. KIDNEY INTERNATIONAL
- Deletion of prolyl hydroxylase domain proteins (PHD1, PHD3) stabilizes hypoxia inducible factor-1 alpha, promotes neovascularization, and improves perfusion in a murine model of hind-limb ischemia
- (2015) Muhammad T. Rishi et al. MICROVASCULAR RESEARCH
- Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes
- (2015) Yutaka Tojo et al. MOLECULAR AND CELLULAR BIOLOGY
- Recent Advances in Developing Inhibitors for Hypoxia-Inducible Factor Prolyl Hydroxylases and Their Therapeutic Implications
- (2015) So Kim et al. MOLECULES
- Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients
- (2015) Anatole Besarab et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Secondary haemochromatosis in a haemodialysis patient
- (2015) L Cheng et al. SINGAPORE MEDICAL JOURNAL
- Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia
- (2015) William Nseir et al. Journal of Diabetes
- Negative regulation of HIF in skeletal muscle of elite endurance athletes: a tentative mechanism promoting oxidative metabolism
- (2014) M. E. Lindholm et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Targeted Gene Deletion of Prolyl Hydroxylase Domain Protein 3 Triggers Angiogenesis and Preserves Cardiac Function by Stabilizing Hypoxia Inducible Factor 1 Alpha Following Myocardial Infarction
- (2014) Babatunde Oriowo et al. CURRENT PHARMACEUTICAL DESIGN
- Magnetic Resonance Imaging Repercussions of Intravenous Iron Products Used for Iron-Deficiency Anemia and Dialysis-Associated Anemia
- (2014) Guy Rostoker et al. JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY
- Association between hemoglobin variability, serum ferritin levels, and adverse events/mortality in maintenance hemodialysis patients
- (2014) Takahiro Kuragano et al. KIDNEY INTERNATIONAL
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- Prevalence of Anemia in Chronic Kidney Disease in the United States
- (2014) Melissa E. Stauffer et al. PLoS One
- Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
- (2014) Anne-Theres Henze et al. Nature Communications
- Regulation of erythropoiesis by hypoxia-inducible factors
- (2013) Volker H. Haase BLOOD REVIEWS
- A randomised single-blind study to improve health-related quality of life by treating anaemia of chronic kidney disease with Aranesp® (darbepoetin alfa) in older people: STIMULATE
- (2013) Simon D. Roger et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Erythrocytosis and Pulmonary Hypertension in a Mouse Model of HumanHIF2AGain of Function Mutation
- (2013) Qiulin Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Knock-in Mouse Model of HumanPHD2Gene-associated Erythrocytosis Establishes a Haploinsufficiency Mechanism
- (2013) Patrick R. Arsenault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes
- (2013) Cullen M Taniguchi et al. NATURE MEDICINE
- Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
- (2013) Francesco Locatelli et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Regulation of IL-1 -induced NF- B by hydroxylases links key hypoxic and inflammatory signaling pathways
- (2013) C. C. Scholz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dose of Erythropoiesis-Stimulating Agents and Adverse Outcomes in CKD: A Metaregression Analysis
- (2012) Ioannis Koulouridis et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- HIF-1 is a protective factor in conditional PHD2-deficient mice suffering from severe HIF-2 -induced excessive erythropoiesis
- (2012) K. Franke et al. BLOOD
- Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
- (2012) Qingdu Liu et al. JOURNAL OF CLINICAL INVESTIGATION
- Deficiency of the oxygen sensor PHD1 augments liver regeneration after partial hepatectomy
- (2012) Martin Mollenhauer et al. LANGENBECKS ARCHIVES OF SURGERY
- Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients
- (2012) Ko-Lin Kuo et al. PLoS One
- Iron Sucrose Promotes Endothelial Injury and Dysfunction and Monocyte Adhesion/Infiltration
- (2011) Vaijinath S. Kamanna et al. AMERICAN JOURNAL OF NEPHROLOGY
- Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression
- (2011) V. R. Gordeuk et al. BLOOD
- Darbepoetin Alfa Impact on Health Status in Diabetes Patients with Kidney Disease: A Randomized Trial
- (2011) E. F. Lewis et al. Clinical Journal of the American Society of Nephrology
- Anemia, inflammation and health-related quality of life in chronic kidney disease patients
- (2011) Y.M.K. Farag et al. CLINICAL NEPHROLOGY
- HIF prolyl hydroxylase inhibitors for anemia
- (2011) Eugene Muchnik et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Hypoxia-Inducible Factor-1α–Dependent Protection from Intestinal Ischemia/Reperfusion Injury Involves Ecto-5′-Nucleotidase (CD73) and the A2B Adenosine Receptor
- (2011) Melanie L. Hart et al. JOURNAL OF IMMUNOLOGY
- Systematic review of the impact of erythropoiesis-stimulating agents on fatigue in dialysis patients
- (2011) K. L. Johansen et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study
- (2011) Tadao Akizawa et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
- (2010) Jodie L. Babitt et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Disruption of Hypoxia-Inducible Transcription Factor-Prolyl Hydroxylase Domain-1 (PHD-1−/−) Attenuates Ex Vivo Myocardial Ischemia/Reperfusion Injury Through Hypoxia-Inducible Factor-1α Transcription Factor and Its Target Genes in Mice
- (2010) Ram Sudheer Adluri et al. ANTIOXIDANTS & REDOX SIGNALING
- Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia
- (2010) P. P. Kapitsinou et al. BLOOD
- The Therapeutic Potential of Erythropoiesis-Stimulating Agents for Tissue Protection: A Tale of Two Receptors
- (2010) Michael Brines BLOOD PURIFICATION
- The Asparaginyl Hydroxylase Factor Inhibiting HIF-1α Is an Essential Regulator of Metabolism
- (2010) Na Zhang et al. Cell Metabolism
- Loss of Prolyl Hydroxylase-1 Protects Against Colitis Through Reduced Epithelial Cell Apoptosis and Increased Barrier Function
- (2010) Murtaza M. Tambuwala et al. GASTROENTEROLOGY
- Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis
- (2010) M. Munoz et al. JOURNAL OF CLINICAL PATHOLOGY
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Erythropoietin stimulating agents in the management of anemia of chronic kidney disease
- (2010) Moro Salifu Patient Preference and Adherence
- Role of the intracellular localization of HIF-prolyl hydroxylases
- (2009) Ken-ichi Yasumoto et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Loss or Silencing of the PHD1 Prolyl Hydroxylase Protects Livers of Mice Against Ischemia/Reperfusion Injury
- (2009) Martin Schneider et al. GASTROENTEROLOGY
- Erythrocytosis associated with a novel missense mutation in the HIF2A gene
- (2009) R. van Wijk et al. HAEMATOLOGICA
- Altitude and All-Cause Mortality in Incident Dialysis Patients
- (2009) Wolfgang C. Winkelmayer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Erythrocytosis-associated HIF-2α Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline
- (2009) Paul W. Furlow et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
- (2009) David R. Mole et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-inducible factor-2α-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization
- (2009) Alexander Paliege et al. KIDNEY INTERNATIONAL
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Autosomal dominant erythrocytosis and pulmonary arterial hypertension associated with an activating HIF2 mutation
- (2008) D. P. Gale et al. BLOOD
- Role and regulation of prolyl hydroxylase domain proteins
- (2008) G-H Fong et al. CELL DEATH AND DIFFERENTIATION
- A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis
- (2008) M. Martini et al. HAEMATOLOGICA
- The angiopoietin-2 gene of endothelial cells is up-regulated in hypoxia by a HIF binding site located in its first intron and by the central factors GATA-2 and Ets-1
- (2008) Marie-Pierre Simon et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The Effect of Altitude on Dosing and Response to Erythropoietin in ESRD
- (2008) M. A. Brookhart et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Proteomics-based Identification of Novel Factor Inhibiting Hypoxia-inducible Factor (FIH) Substrates Indicates Widespread Asparaginyl Hydroxylation of Ankyrin Repeat Domain-containing Proteins
- (2008) Matthew E. Cockman et al. MOLECULAR & CELLULAR PROTEOMICS
- Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3-/- Mice
- (2008) T. Bishop et al. MOLECULAR AND CELLULAR BIOLOGY
- A Gain-of-Function Mutation in theHIF2AGene in Familial Erythrocytosis
- (2008) Melanie J. Percy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction with factor inhibiting HIF-1 defines an additional mode of cross-coupling between the Notch and hypoxia signaling pathways
- (2008) X. Zheng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins
- (2007) K. Takeda et al. BLOOD
- Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis
- (2007) L. Silvestri et al. BLOOD
- The Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis
- (2007) Eoin P. Cummins et al. GASTROENTEROLOGY
- Mucosal Protection by Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibition
- (2007) Andreas Robinson et al. GASTROENTEROLOGY
- Hypoxia-inducible Factor-1α Stabilization in Nonhypoxic Conditions: Role of Oxidation and Intracellular Ascorbate Depletion
- (2007) Elisabeth L. Pagé et al. MOLECULAR BIOLOGY OF THE CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started